Avalo Therapeutics Stock Forecast

Buy candidate since Jun 22, 2026

The Avalo Therapeutics, Inc. stock price gained 16.19% on the last trading day (Monday, 22nd Jun 2026), rising from $14.70 to $17.08. During the last trading day the stock fluctuated 18.35% from a day low at $14.71 to a day high of $17.41. The price has risen in 6 of the last 10 days and is up by 30.38% over the past 2 weeks. Volume fell on the last day by -4 million shares and in total, 3 million shares were bought and sold for approximately $42.84 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 3.55% during the next 3 months and, with a 90% probability hold a price between $13.31 and $24.08 at the end of this 3-month period.

AVTX Signals & Forecast

Mostly positive signals in the chart today. The Avalo Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $14.93 and $16.17. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, June 08, 2026, and so far it has risen 34.07%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Avalo Therapeutics, Inc. stock

Avalo Therapeutics, Inc. finds support from accumulated volume at $16.27 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $2.70 between high and low, or 18.35%. For the last week, the stock has had daily average volatility of 9.19%.

Our recommended stop-loss: $16.51 (-3.36%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 9 days ago.)

Trading Expectations (AVTX) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect Avalo Therapeutics, Inc. to open at $16.40, and during the day (based on 14 day Average True Range), to move between $16.45 and $17.71, which gives a possible trading interval of +/-$1.25 (+/-7.61%) up or down from last closing price. If Avalo Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 7.61% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $16.27 (4.74%) than the resistance at $19.01 (11.30%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Avalo Therapeutics, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Avalo Therapeutics, Inc. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 4.391 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $16.40 ( 3.98%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk